Treatment as Prevention¨

Gilead reports new data from Discover trial

Gilead Sciences (NASDAQ:GILD) announces findings from the DISCOVER trial evaluating Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) for HIV pre-exposure prophylaxis (PrEP), showing significant improvements in key measures of bone and renal safety parameters in a subset of study participants who switched from Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate

Gilead reports new data from Discover trial Read More »

The AIDS Pandemic Is Not Over, Says AIDS & LGBT Rights Activist Cleve Jones

In the early ’80s, formerly healthy gay men began developing an unknown disease. Men started dying. What started as a few men, skyrocketed into thousands. Communities in New York, San Francisco, and other U.S. cities were decimated. “We had no effective treatment. We had a government that was not particularly concerned. There was a lot

The AIDS Pandemic Is Not Over, Says AIDS & LGBT Rights Activist Cleve Jones Read More »

Man says his partner never disclosed HIV positive status, which is against the law

AUGUSTA, Ga. (WJBF) – Human immunodeficiency virus ranks high in both Georgia and Richmond County. Many health experts say that’s because people are either not aware of their HIV status or they do not disclose it, which is against the law. One man reached out to NewsChannel 6 and said the lack of disclosure turned

Man says his partner never disclosed HIV positive status, which is against the law Read More »

Why We Still Need a National Gay Men’s HIV/AIDS Awareness Day

Nearly four decades ago, thousands of young healthy gay and bi men suddenly became sick, withered and died. Before doctors and epidemiologists could agree on what the strange illness was, it was called “gay cancer” or Gay Related Immune Deficiency (GRID), later Acquired Immune Deficiency Syndrome (AIDS), and now we know it’s caused by the

Why We Still Need a National Gay Men’s HIV/AIDS Awareness Day Read More »

‘Test and treat’ programmes are failing to reach people at highest risk of HIV transmission

Programmes to scale-up HIV testing and treatment in countries in sub-Saharan Africa may have had less impact on new HIV infections than hoped, partly because they haven’t paid enough attention to groups that contribute disproportionately to HIV acquisition and transmission, experts say. Greater efforts should be made to ensure that ‘universal test and treat’ programmes

‘Test and treat’ programmes are failing to reach people at highest risk of HIV transmission Read More »

The Berlin Patient: Cured of HIV with a stem cell transplant, Timothy Brown visits Vancouver

An anonymous stem cell donor cured Timothy Ray Brown of both his leukemia and his HIV. For years, experts wondered whether it was a cure or just a temporary remission. It’s been 11 years. Brown is still HIV and cancer-free. Brown, 53, is now frequently asked to speak around the world to scientists, people with

The Berlin Patient: Cured of HIV with a stem cell transplant, Timothy Brown visits Vancouver Read More »

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)